» Articles » PMID: 17854503

Structure-function Analysis of the Retinoblastoma Tumor Suppressor Protein - is the Whole a Sum of Its Parts?

Overview
Journal Cell Div
Publisher Biomed Central
Date 2007 Sep 15
PMID 17854503
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Biochemical analysis of the retinoblastoma protein's function has received considerable attention since it was cloned just over 20 years ago. During this time pRB has emerged as a key regulator of the cell division cycle and its ability to block proliferation is disrupted in the vast majority of human cancers. Much has been learned about the regulation of E2F transcription factors by pRB in the cell cycle. However, many questions remain unresolved and researchers continue to explore this multifunctional protein. In particular, understanding how its biochemical functions contribute to its role as a tumor suppressor remains to be determined. Since pRB has been shown to function as an adaptor molecule that links different proteins together, or to particular promoters, analyzing pRB by disrupting individual protein interactions holds tremendous promise in unraveling the intricacies of its function. Recently, crystal structures have reported how pRB interacts with some of its molecular partners. This information has created the possibility of rationally separating pRB functions by studying mutants that disrupt individual binding sites. This review will focus on literature that investigates pRB by isolating functions based on binding sites within the pocket domain. This article will also discuss the prospects for using this approach to further explore the unknown functions of pRB.

Citing Articles

Retinoblastoma protein activity revealed by CRISPRi study of divergent Rbf1 and Rbf2 paralogs.

Raicu A, Castanheira P, Arnosti D G3 (Bethesda). 2024; .

PMID: 39365155 PMC: 11631494. DOI: 10.1093/g3journal/jkae238.


HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes.

Barrett A, Shingare M, Rechtsteiner A, Rodriguez K, Le Q, Wijeratne T Nat Commun. 2024; 15(1):4450.

PMID: 38789411 PMC: 11126580. DOI: 10.1038/s41467-024-48724-0.


HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes.

Barrett A, Shingare M, Rechtsteiner A, Wijeratne T, Rodriguez K, Rubin S bioRxiv. 2023; .

PMID: 37961464 PMC: 10634886. DOI: 10.1101/2023.10.28.564489.


RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).

Kugalingam N, Silva D, Abeysekera H, Nanayakkara S, Tirimanne S, Ranaweera D BMC Med Genomics. 2023; 16(1):279.

PMID: 37932687 PMC: 10626775. DOI: 10.1186/s12920-023-01721-6.


Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation.

Zluhan-Martinez E, Perez-Koldenkova V, Ponce-Castaneda M, de la Paz Sanchez M, Garcia-Ponce B, Miguel-Hernandez S Int J Mol Sci. 2020; 21(14).

PMID: 32664691 PMC: 7404004. DOI: 10.3390/ijms21144925.


References
1.
Isaac C, Francis S, Martens A, Julian L, Seifried L, Erdmann N . The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol. 2006; 26(9):3659-71. PMC: 1447412. DOI: 10.1128/MCB.26.9.3659-3671.2006. View

2.
Ledl A, Schmidt D, Muller S . Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene. 2005; 24(23):3810-8. DOI: 10.1038/sj.onc.1208539. View

3.
DeCaprio J, Ludlow J, Figge J, Shew J, Huang C, Lee W . SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 1988; 54(2):275-83. DOI: 10.1016/0092-8674(88)90559-4. View

4.
Chau B, Pan C, Wang J . Separation of anti-proliferation and anti-apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domain. PLoS One. 2006; 1:e82. PMC: 1762320. DOI: 10.1371/journal.pone.0000082. View

5.
Lundberg A, Weinberg R . Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol. 1998; 18(2):753-61. PMC: 108786. DOI: 10.1128/MCB.18.2.753. View